"New breast cancer drug shown to prolong life"
Source: Sydney Morning Herald
Published: 04 Jun 2012
Category: Pharmaceutical
Rating:
(3½ stars)
Keywords: breast cancer clinical trial prognosis
what they said (Hover the mouse cursor over underlined words for more info)
A DRUG that delivers a powerful poison to tumours without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to prolong lives, according to a new study.
The original article can be found at: http://www.smh.com.au/national/health/new-breast-cancer-drug-shown-to-prolong-life-20120603-1zq36.html
| Criteria |
Rating |
| Novelty of Treatment |
Not Satisfactory (?) |
| Availability of Treatment |
Satisfactory (?) |
| Treatment Options |
Satisfactory (?) |
| Disease Mongering |
Satisfactory (?) |
| Evidence |
Satisfactory (?) |
| Quantification of Benefits of Treatment |
Satisfactory (?) |
| Harms of Treatment |
Not Satisfactory (?) |
| Costs of Treatment |
Not Applicable |
| Sources of Information |
Not Satisfactory (?) |
| Relies on Press Release |
Not Applicable |
what we said (Hover the mouse cursor over underlined words for more info)
This is a good story about new research on breast cancer treatment. It makes clear that the evidence comes from a conference presentation rather than an article in a peer reviewed journal (a higher level of evidence). However the story does not discuss the fact that there are several monoclonal antibody treatments already on the market.
The story has been imported from the New York Times and although it rates well, its readers would have benefited from local independent expert comment.
public forum
There are currently no comments on this article.
|